Memory and Aging Center, Department of Neurology, University of California San Francisco, USA.
Neurology. 2013 May 21;80(21):1973-7. doi: 10.1212/WNL.0b013e318293e368. Epub 2013 May 1.
To evaluate the interrater reliability of the new International Behavioural Variant FTD Criteria Consortium (FTDC) criteria for behavioral variant frontotemporal dementia (bvFTD).
Twenty standardized clinical case modules were developed for patients with a range of neurodegenerative diagnoses, including bvFTD, primary progressive aphasia (nonfluent, semantic, and logopenic variant), Alzheimer disease, and Lewy body dementia. Eighteen blinded raters reviewed the modules and 1) rated the presence or absence of core diagnostic features for the FTDC criteria, and 2) provided an overall diagnostic rating. Interrater reliability was determined by κ statistics for multiple raters with categorical ratings.
The mean κ value for diagnostic agreement was 0.81 for possible bvFTD and 0.82 for probable bvFTD ("almost perfect agreement"). Interrater reliability for 4 of the 6 core features had "substantial" agreement (behavioral disinhibition, perseverative/compulsive, sympathy/empathy, hyperorality; κ = 0.61-0.80), whereas 2 had "moderate" agreement (apathy/inertia, neuropsychological; κ = 0.41-0.6). Clinician years of experience did not significantly influence rater accuracy.
The FTDC criteria show promise for improving the diagnostic accuracy and reliability of clinicians and researchers. As disease-altering therapies are developed, accurate differential diagnosis between bvFTD and other neurodegenerative diseases will become increasingly important.
评估新的国际行为变异额颞叶痴呆标准联盟(FTDC)行为变异额颞叶痴呆(bvFTD)标准的观察者间可靠性。
为一系列神经退行性诊断患者,包括 bvFTD、原发性进行性失语症(非流利型、语义型和失语法型)、阿尔茨海默病和路易体痴呆症,开发了 20 个标准化临床案例模块。18 名盲审员审查了这些模块,并 1)评估了 FTDC 标准的核心诊断特征的存在或缺失,以及 2)提供了整体诊断评分。多位评分者的分类评分的κ统计用于确定观察者间可靠性。
可能 bvFTD 的平均κ值为 0.81,可能 bvFTD 的平均κ值为 0.82(“几乎完美一致”)。6 个核心特征中的 4 个具有“实质性”一致性(行为抑制障碍、持续/强迫、同情/同理心、食欲亢进;κ=0.61-0.80),而 2 个具有“中度”一致性(冷漠/无动力、神经心理学;κ=0.41-0.6)。临床医生的工作年限并没有显著影响评分者的准确性。
FTDC 标准有望提高临床医生和研究人员的诊断准确性和可靠性。随着改变疾病的治疗方法的发展,bvFTD 与其他神经退行性疾病之间的准确鉴别诊断将变得越来越重要。